Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
第一著者: | Karim, Samia Binte |
---|---|
その他の著者: | Azam, Faruque |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
Brac University
2024
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/23944 |
類似資料
-
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
著者:: Hoque, Ismoth Ara
出版事項: (2024) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
著者:: Paul, Pulock
出版事項: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
著者:: Rahman, Tasnim
出版事項: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
著者:: Flora, Sanzida Alam
出版事項: (2024) -
Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
著者:: Hasan, Sakib
出版事項: (2024)